← Back to Search

Monoclonal Antibodies

Participants with CD30-positive Lymphoma for Lymphoma

N/A
Recruiting
Research Sponsored by Takeda
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year and 2 years
Awards & highlights

Summary

Participants with CD30-positive lympoma will be treated with brentuximab vedotin according to their clinic's standard practice. The main aim of this study is to collect information on any side effects from treatment with brentuximab vedotin. Other aims are to collect information on how brentuximab vedotin is used to treat these participants and the outcomes of these participants.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year and 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change From Baseline in Quality of Life (QoL) Assessed Using Functional Assessment of Cancer Therapy Lymphoma (FACT-Lym) Questionnaire Version 4
Cost-effectiveness Ratio
Duration of Response (DOR)
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants with CD30-positive LymphomaExperimental Treatment1 Intervention
All participants diagnosed with CD30-positive lymphoma who are receiving or will recieve brentuximab vedotin will be observed prospectively over 24-month period, unless withdrawal of informed consent, lost or death, whichever comes first.

Find a Location

Who is running the clinical trial?

TakedaLead Sponsor
1,227 Previous Clinical Trials
4,221,505 Total Patients Enrolled
45 Trials studying Lymphoma
12,575 Patients Enrolled for Lymphoma
Study DirectorStudy DirectorTakeda
1,252 Previous Clinical Trials
503,379 Total Patients Enrolled
43 Trials studying Lymphoma
9,965 Patients Enrolled for Lymphoma
~71 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top